CDSCO

CDSCO Invites Public Comments on Proposal for Brand Name Extensions in Pharmaceutical Products

Posted by: Prabhas Chakraborty July 14, 2026

Drugs (Ninth Amendment) Rules, 2026 – Inclusion of Navi Mumbai as Authorized Drug Import Airport.

Posted by: Hitesh Gupta July 9, 2026

CDSCO updated list of laboratories to conduct Performance evaluation of IVDs dated 29/06/2026

Posted by: Hitesh Gupta July 1, 2026

2026.06.23 G.S.R. 509(E)_ Draft notification regarding simplification of the process for obtaining test licences for import of drugs under Form 11 of the Drugs Rules, 1945

Posted by: Hitesh Gupta July 1, 2026

2026.06.23 515(E)_Draft notification regarding amendments under Medical Devices Rules 2017

Posted by: Hitesh Gupta July 1, 2026

Submission of Post Approval Changes Applications of Registration Certificate and Import Licence of Human Vaccines and Anti-sera through SUGAM Portal

Posted by: Hitesh Gupta June 26, 2026

Sale of In-Vitro Fertilization media, reagents and related consumables used in Assisted Reproductive Technology procedures

Posted by: Hitesh Gupta June 26, 2026

Regulation of Formulation intermediates such as Directly Compressible granules, Taste masked granules, Modified release granules / Pellets

Posted by: Hitesh Gupta June 26, 2026

What's New 2?

Regulation/Guidelines

Vaccine Regulatory Approval in India: Pathway for Global Manufacturers

India occupies a unique position in the global vaccine ecosystem — simultaneously the world's largest vaccine manufacturer by volume (producing approximately 60% of the world's vaccines), a significant importer for...

17th July, 2026

Regulation/Guidelines

Regulatory Strategy as a Development Accelerator: How to Compress Clinical Trial Timelines in India

In Pharmaceutical development, time is capital. Every month of delay between trial design and first patient enrolled has a quantifiable cost - in direct operational expenditure, in foregone revenue from...

16th July, 2026

Regulation/Guidelines

Retaining Your Cosmetic Import Registration Certificate (COS-2) in India: What Happens at the 5-Year Mark

The Certificate That Does Not Automatically Renew The COS-2 Import Registration Certificate is valid for five years from the date of issue. When it expires, the right to import and...

15th July, 2026

Regulation/Guidelines

Preparing for CDSCO Inspection: Documentation, Site Readiness, and Common Reasons for Delay

A CDSCO inspection is one of the most consequential events in a Medical Device company's regulatory journey in India. Whether you are a manufacturer or Importer, demonstrating compliance with the...

14th July, 2026

CDSCO

CDSCO

CDSCO Invites Public Comments on Proposal for Brand Name Extensions in Pharmaceutical Products

Drugs (Ninth Amendment) Rules, 2026 – Inclusion of Navi Mumbai as Authorized Drug Import Airport.

CDSCO updated list of laboratories to conduct Performance evaluation of IVDs dated 29/06/2026

2026.06.23 G.S.R. 509(E)_ Draft notification regarding simplification of the process for obtaining test licences for import of drugs under Form 11 of the Drugs Rules, 1945

2026.06.23 515(E)_Draft notification regarding amendments under Medical Devices Rules 2017

Submission of Post Approval Changes Applications of Registration Certificate and Import Licence of Human Vaccines and Anti-sera through SUGAM Portal

Sale of In-Vitro Fertilization media, reagents and related consumables used in Assisted Reproductive Technology procedures

Regulation of Formulation intermediates such as Directly Compressible granules, Taste masked granules, Modified release granules / Pellets

For Importers To India

Drug

Biologicals

Food Supplements

Medical Device

IVD

Food

Cosmetic

Other

For Manufacturer in India

Drug

Biologicals

Food Supplements

Food

Medical Device

IVD

Cosmetic

Other